Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jeff Baxter Insider Profile
4 Followers
Jeff Baxter, CEO & President, Director at VBI Vaccines, holds 608.25K shares in VBI Vaccines (Ticker: VBIV), holds ― shares in Chromadex (Ticker: CDXC). Most recently, Jeff Baxter Bought ― shares of VBI Vaccines on Sep 30, 2019 for an estimated value of 75.00K.
Jeff Baxter VBI Vaccines (VBIV)CEO & President, Director
VBI Vaccines (VBIV)
CEO & President, Director
Ranked #7,642 out of 98,624 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+386.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jeff Baxter holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jeff Baxter
Jeff Baxter's Trading History
VBI Vaccines
Sep 30, 2019
CEO & President, Director
Informative Buy
75.00K
$358.87K
Chromadex
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Jeff Baxter's performance on stock
You May Also Like
Jeff Baxter insider profile FAQ
What is the percentage of profitable transactions made by Jeff Baxter?
The percentage of profitable transactions made by Jeff Baxter is 100%.
What is the average return per transaction made by Jeff Baxter?
The average return per transaction made by Jeff Baxter is 386.60%.
What stocks does Jeff Baxter hold?
Jeff Baxter holds: VBIV, CDXC stocks.
What was Jeff Baxter’s latest transaction?
Jeff Baxter latest transaction was an Informative Buy of $75.00K.
What was Jeff Baxter's most profitable transaction?
Jeff Baxter’s most profitable transaction was an Informative Buy of VBIV stock on September 30, 2019. The return on the trade was 506.90%.
What is Jeff Baxter's role in VBI Vaccines?
Jeff Baxter's role in VBI Vaccines is CEO & President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.